FGFR2–BRD4 Axis Regulates Transcriptional Networks of Histone 3 Modification and Synergy Between Its Inhibitors and PD-1/PD-L1 in a TNBC Mouse Model
Epigenetic reprogramming is an independent mode of gene expression that often involves changes in the transcription and chromatin structure due to tumor initiation and development. In this study, we developed a specifically modified peptide array and searched for a recognized epigenetic reader. Our...
Main Authors: | Josh Haipeng Lei, Lei Zhang, Zhenyi Wang, Raoul Peltier, Yusheng Xie, Ganchao Chen, Shiqi Lin, Kai Miao, Chu-Xia Deng, Hongyan Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.861221/full |
Similar Items
-
Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression
by: Julie Xia Zhou, et al.
Published: (2022-12-01) -
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
by: Jing-Bo Zhou, et al.
Published: (2023-08-01) -
BRD4 as a Therapeutic Target in Pulmonary Diseases
by: Xia Guo, et al.
Published: (2023-08-01) -
Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
by: Cunte Chen, et al.
Published: (2021-02-01) -
BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells
by: Su-Lim Kim, et al.
Published: (2023-11-01)